Literature DB >> 25592038

Hepatocyte nuclear factor 4 alpha promotes the invasion, metastasis and angiogenesis of neuroblastoma cells via targeting matrix metalloproteinase 14.

Xuan Xiang1, Xiang Zhao1, Hongxia Qu1, Dan Li1, Dehua Yang1, Jiarui Pu1, Hong Mei1, Jihe Zhao2, Kai Huang3, Liduan Zheng4, Qiangsong Tong5.   

Abstract

Matrix metalloproteinase 14 (MMP-14) is the only membrane-anchored MMP that plays critical roles in tumorigenesis and aggressiveness. However, the regulatory mechanisms underlying the high MMP-14 expression in neuroblastoma (NB), a highly malignant tumor in childhood, still remain unclear. Herein, we applied an integrative approach to analyze the public datasets, and identified hepatocyte nuclear factor 4 alpha (HNF4α) as a crucial transcription factor facilitating the MMP-14 expression in NB. In clinical NB tissues, HNF4α was up-regulated and positively correlated with MMP-14 expression, and was an independent prognostic factor for unfavorable outcome of patients. Luciferase reporter and chromatin immunoprecipitation assays indicated that HNF4α directly targeted the binding site within the MMP-14 promoter to facilitate its transcription. Knockdown of HNF4α suppressed the invasion, metastasis and angiogenesis of NB cells in vitro and in vivo. Conversely, ectopic expression of HNF4α promoted the invasion, metastasis and angiogenesis of NB cells. Importantly, restoration of MMP-14 expression prevented the tumor cells from HNF4α-mediated changes in these biological features. Taken together, HNF4α exhibits oncogenic activity that affects the aggressiveness and angiogenesis of NB through activating the transcription of MMP-14.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hepatocyte nuclear factor 4 alpha; Matrix metalloproteinase 14; Neuroblastoma; Transcriptional regulation

Mesh:

Substances:

Year:  2015        PMID: 25592038     DOI: 10.1016/j.canlet.2015.01.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.

Authors:  Xiang Zhao; Dan Li; Feng Yang; Heng Lian; Jianqun Wang; Xiaojing Wang; Erhu Fang; Huajie Song; Anpei Hu; Yanhua Guo; Yang Liu; Hongjun Li; Yajun Chen; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Mol Ther       Date:  2020-01-11       Impact factor: 11.454

2.  TGF-β inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis, and transcriptional downregulation of megalin.

Authors:  Luciana C Mazzocchi; Christine U Vohwinkel; Konstantin Mayer; Susanne Herold; Rory E Morty; Werner Seeger; István Vadász
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-13       Impact factor: 5.464

3.  HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.

Authors:  Wanju Jiao; Yajun Chen; Huajie Song; Dan Li; Hong Mei; Feng Yang; Erhu Fang; Xiaojing Wang; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

4.  Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.

Authors:  Xiang Zhao; Dan Li; Dandan Huang; Huajie Song; Hong Mei; Erhu Fang; Xiaojing Wang; Feng Yang; Liduan Zheng; Kai Huang; Qiangsong Tong
Journal:  Mol Ther       Date:  2017-12-22       Impact factor: 11.454

5.  CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.

Authors:  X Zhao; D Li; J Pu; H Mei; D Yang; X Xiang; H Qu; K Huang; L Zheng; Q Tong
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

6.  miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.

Authors:  Xuan Xiang; Hong Mei; Xiang Zhao; Jiarui Pu; Dan Li; Hongxia Qu; Wanju Jiao; Jihe Zhao; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Oncotarget       Date:  2015-09-08

7.  Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.

Authors:  Maria V Bogachek; Jung M Park; James P De Andrade; Allison W Lorenzen; Mikhail V Kulak; Jeffrey R White; Vivian W Gu; Vincent T Wu; Ronald J Weigel
Journal:  Stem Cell Reports       Date:  2016-12-01       Impact factor: 7.765

8.  Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase.

Authors:  Hongxia Qu; Liduan Zheng; Wanju Jiao; Hong Mei; Dan Li; Huajie Song; Erhu Fang; Xiaojing Wang; Shiwang Li; Kai Huang; Qiangsong Tong
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

9.  microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.

Authors:  Hongxia Qu; Liduan Zheng; Huajie Song; Wanju Jiao; Dan Li; Erhu Fang; Xiaojing Wang; Hong Mei; Jiarui Pu; Kai Huang; Qiangsong Tong
Journal:  Oncotarget       Date:  2016-06-28

10.  miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.

Authors:  Liduan Zheng; Wanju Jiao; Hong Mei; Huajie Song; Dan Li; Xuan Xiang; Yajun Chen; Feng Yang; Huanhuan Li; Kai Huang; Qiangsong Tong
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.